AU2003244635A1 - Process for the purification of interleukin-4 and its muteins - Google Patents
Process for the purification of interleukin-4 and its muteinsInfo
- Publication number
- AU2003244635A1 AU2003244635A1 AU2003244635A AU2003244635A AU2003244635A1 AU 2003244635 A1 AU2003244635 A1 AU 2003244635A1 AU 2003244635 A AU2003244635 A AU 2003244635A AU 2003244635 A AU2003244635 A AU 2003244635A AU 2003244635 A1 AU2003244635 A1 AU 2003244635A1
- Authority
- AU
- Australia
- Prior art keywords
- interleukin
- muteins
- purification
- derivatives
- expressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004388 Interleukin-4 Human genes 0.000 title abstract 3
- 108090000978 Interleukin-4 Proteins 0.000 title abstract 3
- 229940028885 interleukin-4 Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 210000003000 inclusion body Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5406—IL-4
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02015589A EP1382614A1 (en) | 2002-07-15 | 2002-07-15 | Process for the purification of interleukin-4 and its muteins |
| EP02015589.1 | 2002-07-15 | ||
| PCT/EP2003/007022 WO2004007549A1 (en) | 2002-07-15 | 2003-07-02 | Process for the purification of interleukin-4 and its muteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003244635A1 true AU2003244635A1 (en) | 2004-02-02 |
Family
ID=29762614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003244635A Abandoned AU2003244635A1 (en) | 2002-07-15 | 2003-07-02 | Process for the purification of interleukin-4 and its muteins |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20060134690A1 (enExample) |
| EP (2) | EP1382614A1 (enExample) |
| JP (2) | JP2006506332A (enExample) |
| AT (1) | ATE352566T1 (enExample) |
| AU (1) | AU2003244635A1 (enExample) |
| DE (1) | DE60311470T2 (enExample) |
| ES (1) | ES2280764T3 (enExample) |
| WO (1) | WO2004007549A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1382614A1 (en) * | 2002-07-15 | 2004-01-21 | Bayer HealthCare AG | Process for the purification of interleukin-4 and its muteins |
| US8189621B2 (en) | 2006-05-12 | 2012-05-29 | Microsoft Corporation | Stack signaling to application with lack of requested bandwidth |
| US8144793B2 (en) | 2006-12-12 | 2012-03-27 | Microsoft Corporation | Cognitive multi-user OFDMA |
| US8268604B2 (en) * | 2007-12-20 | 2012-09-18 | Abbott Point Of Care Inc. | Compositions for forming immobilized biological layers for sensing |
| US8241697B2 (en) * | 2007-12-20 | 2012-08-14 | Abbott Point Of Care Inc. | Formation of immobilized biological layers for sensing |
| KR101113495B1 (ko) | 2008-01-23 | 2012-02-29 | 한미홀딩스 주식회사 | 인간 인터페론 베타의 정제방법 |
| US20110034678A1 (en) * | 2009-03-13 | 2011-02-10 | Aerovance, Inc. | Methods of renaturation of recombinant proteins |
| EP2427215A1 (en) * | 2009-05-07 | 2012-03-14 | Novo Nordisk Health Care AG | Stable pharmaceutical compositions of peptide derivatized using an oxime linker |
| WO2012028525A2 (en) * | 2010-08-30 | 2012-03-08 | F. Hoffmann-La Roche Ag | Method for producing a lipid particle, the lipid particle itself and its use |
| WO2012028524A2 (en) * | 2010-08-30 | 2012-03-08 | F. Hoffmann-La Roche Ag | Method for producing a lipid particle, the lipid particle itself and its use |
| CN103320447A (zh) * | 2013-05-20 | 2013-09-25 | 深圳市亚太兴实业有限公司 | 重组人白介素4基因、含重组人白介素4基因的工程菌发酵方法 |
| CN108753753B (zh) * | 2018-05-28 | 2022-04-22 | 中国林业科学研究院林业研究所 | Lrr受体激酶-pxy的纯化方法 |
| MX2022001975A (es) | 2019-08-16 | 2022-03-11 | Applied Molecular Transport Inc | Composiciones, formulaciones y produccion y purificacion de interleucinas. |
| CN116874552B (zh) * | 2023-09-08 | 2023-12-08 | 成都华任康生物科技有限公司 | 一种目标蛋白的纯化方法及其试剂盒和相关应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4137333A1 (de) * | 1991-11-13 | 1993-05-19 | W Prof Dr Sebald | Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung |
| NZ261571A (en) * | 1993-02-04 | 1997-03-24 | Denzyme Aps | Producing correctly folded proteins using multiple denaturation and renaturation cycles |
| US5563057A (en) * | 1994-10-31 | 1996-10-08 | Wisconsin Alumni Research Foundation | Method for refolding misfolded enzymes with detergent and cyclodextrin |
| JP3344618B2 (ja) * | 1997-06-20 | 2002-11-11 | 株式会社エイチ・エス・ピー研究所 | シャペロン発現プラスミド |
| US5932102A (en) * | 1998-01-12 | 1999-08-03 | Schering Corporation | Immobilized metal, affinity chromatography |
| EP1382614A1 (en) * | 2002-07-15 | 2004-01-21 | Bayer HealthCare AG | Process for the purification of interleukin-4 and its muteins |
-
2002
- 2002-07-15 EP EP02015589A patent/EP1382614A1/en not_active Withdrawn
-
2003
- 2003-07-02 DE DE60311470T patent/DE60311470T2/de not_active Expired - Lifetime
- 2003-07-02 US US10/520,883 patent/US20060134690A1/en not_active Abandoned
- 2003-07-02 JP JP2004520457A patent/JP2006506332A/ja active Pending
- 2003-07-02 EP EP03738109A patent/EP1523500B1/en not_active Expired - Lifetime
- 2003-07-02 WO PCT/EP2003/007022 patent/WO2004007549A1/en not_active Ceased
- 2003-07-02 ES ES03738109T patent/ES2280764T3/es not_active Expired - Lifetime
- 2003-07-02 AT AT03738109T patent/ATE352566T1/de not_active IP Right Cessation
- 2003-07-02 AU AU2003244635A patent/AU2003244635A1/en not_active Abandoned
-
2010
- 2010-11-12 US US12/945,829 patent/US20110060128A1/en not_active Abandoned
- 2010-12-24 JP JP2010288204A patent/JP2011088922A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE60311470T2 (de) | 2007-10-31 |
| EP1382614A1 (en) | 2004-01-21 |
| US20110060128A1 (en) | 2011-03-10 |
| WO2004007549A1 (en) | 2004-01-22 |
| JP2006506332A (ja) | 2006-02-23 |
| ATE352566T1 (de) | 2007-02-15 |
| JP2011088922A (ja) | 2011-05-06 |
| DE60311470D1 (de) | 2007-03-15 |
| US20060134690A1 (en) | 2006-06-22 |
| ES2280764T3 (es) | 2007-09-16 |
| EP1523500B1 (en) | 2007-01-24 |
| EP1523500A1 (en) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003218169A1 (en) | Method for the purification, production and formulation of oncolytic adenoviruses | |
| ATE352566T1 (de) | Verfahren zur reinigung von interleukin-4 und seinen muteinen | |
| AU2003208106A1 (en) | Silicon purifying method, slag for purifying silicon, and purified silicon | |
| WO2000044928A3 (en) | Materials and methods for the purification of polyelectrolytes | |
| IL165434A0 (en) | Compounds having DPP-IV inhibitory activity | |
| HU9501569D0 (en) | Oxalyl-amino-benzo-furane- and benzo-thienyl-derivatives, process for producing them and pharmaceutical compositions containing them | |
| NO302474B1 (no) | Sakarinderivater, farmasöytisk sammensetning og anvendelse derav | |
| DE60332163D1 (de) | Zusammensetzung zur hautaufhellung | |
| DK1100880T3 (da) | Urat oxidase | |
| ATE233250T1 (de) | Saccharinderivate als proteolytische enzyminhibitoren | |
| AU2003251797A1 (en) | Methods and compositions for the production, identification and purification of fusion proteins | |
| AU2003235720A1 (en) | Method for the production and purification of 1,7'-dimethyl-2'-propyl-2,5'-bi-1h-benzimidazole | |
| PL376576A1 (pl) | Tiazolo(bi)cykloalkilokarboksyanilidy | |
| AU2003232775A1 (en) | Oxathiincarboxamides | |
| ATE481474T1 (de) | Mikrobielles verfahren zur herstellung von arginin | |
| AU2002328909A1 (en) | Nucleic acid molecules encoding proteins essential for plant growth | |
| AU2321900A (en) | Process for the preparation of alpha-aminoketones | |
| AU2003259185A1 (en) | Process for regulating gene expression | |
| AU2003227622A1 (en) | Methylthiophene carboxanilides | |
| BR0112123A (pt) | Composto | |
| EP1870454A4 (en) | PROCESS FOR DIPEPTIDE PRODUCTION | |
| TW200722435A (en) | Purification of proteins with cationic surfactant | |
| AU2003281677B2 (en) | Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids | |
| AU2003902414A0 (en) | Flowering induction | |
| AU2003202489A1 (en) | Screening method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |